BLRX

BioLineRX
BLRX

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $5.12M invested in BioLineRX in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$175K
2
+$146K
3
+$69.5K
4
TRCT
Tower Research Capital (TRC)
New York
+$4K

Top Sellers

1
-$557K
2
-$25K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.92M
2
$1.51M
3
$446K
4
$135K
5
$39K
6
$27K
7
$24K
8
$4K
9
$2K
10
$1K
11
–